{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:21:01Z","timestamp":1793661661563,"version":"4.5.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"am","delay-in-days":380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.clinre.2019.10.003","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T22:16:23Z","timestamp":1573078583000},"page":"264-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review"],"prefix":"10.1016","volume":"44","author":[{"given":"Manon","family":"Allaire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Cadranel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Thu Nga","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Garioud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honore","family":"Zougmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratmony","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Perignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ollivier-Hourmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00f4ng","family":"Dao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clinre.2019.10.003_bib0350","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013","volume":"60","author":"Jalan","year":"2014","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2019.10.003_bib0355","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"European Association for the study of the liver","year":"2018","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.clinre.2019.10.003_bib0360","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2019.10.003_bib0365","doi-asserted-by":"crossref","first-page":"16041","DOI":"10.1038\/nrdp.2016.41","article-title":"Acute-on-chronic liver failure in cirrhosis","volume":"2","author":"Arroyo","year":"2016","journal-title":"Nat Rev Dis Primer"},{"issue":"4","key":"10.1016\/j.clinre.2019.10.003_bib0370","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis","volume":"139","author":"Arvaniti","year":"2010","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.clinre.2019.10.003_bib0375","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.25532","article-title":"Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study","volume":"55","author":"Fern\u00e1ndez","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clinre.2019.10.003_bib0380","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1378\/chest.124.3.1016","article-title":"Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey","volume":"124","author":"Foreman","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.clinre.2019.10.003_bib0385","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.21443","article-title":"Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features","volume":"45","author":"Fasolato","year":"2007","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.clinre.2019.10.003_bib0390","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.dld.2018.05.013","article-title":"Prevalence, predictors and impact of bacterial infection in acute on chronic liver failure patients","volume":"50","author":"Shalimar","year":"2018","journal-title":"Dis Liv Dis"},{"issue":"1","key":"10.1016\/j.clinre.2019.10.003_bib0395","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.dld.2018.01.007","article-title":"Epidemiology, predictors and outcomes of multi drug resistant (MDR) bacterial infections in patients with cirrhosis across the world. Final results of the \u201cGlobal study\u201d","volume":"50","author":"Piano","year":"2018","journal-title":"Dig Liver Dis"},{"issue":"10","key":"10.1016\/j.clinre.2019.10.003_bib0400","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","article-title":"Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis","volume":"67","author":"Fern\u00e1ndez","year":"2018","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.clinre.2019.10.003_bib0405","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/jhep.2002.30082","article-title":"Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis","volume":"35","author":"Fern\u00e1ndez","year":"2002","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.clinre.2019.10.003_bib0410","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4254\/wjh.v7.i7.916","article-title":"Multiresistant bacterial infections in liver cirrhosis: clinical impact and new empirical antibiotic treatment policies","volume":"7","author":"Acevedo","year":"2015","journal-title":"World J Hepatol"},{"issue":"11","key":"10.1016\/j.clinre.2019.10.003_bib0415","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.cgh.2012.08.017","article-title":"High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US Liver Center","volume":"10","author":"Tandon","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"07","key":"10.1016\/j.clinre.2019.10.003_bib0420","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1086\/501929","article-title":"Carriage of Staphylococcus aureus and of Gram-Negative Bacilli Resistant to Third-Generation Cephalosporins in Cirrhotic Patients A Prospective Assessment of Hospital-Acquired Infections","volume":"22","author":"Dupeyron","year":"2001","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.clinre.2019.10.003_bib0425","doi-asserted-by":"crossref","first-page":"e0127448","DOI":"10.1371\/journal.pone.0127448","article-title":"The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey","volume":"10","author":"Merli","year":"2015","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.clinre.2019.10.003_bib0430","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/hep.23264","article-title":"Severe sepsis in cirrhosis","volume":"50","author":"Gustot","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2019.10.003_bib0435","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.clinre.2019.10.003_bib0440","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/hep.24789","article-title":"Intestinal bacterial translocation in rats with cirrhosis is related to compromised paneth cell antimicrobial host defense","volume":"55","author":"Teltschik","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clinre.2019.10.003_bib0445","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1053\/jhep.2003.50116","article-title":"Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats","volume":"37","author":"Lorenzo-Z\u00fa\u00f1iga","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2019.10.003_bib0450","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/hep.27941","article-title":"The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial","volume":"63","author":"Piano","year":"2001","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clinre.2019.10.003_bib0455","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0168-8278(99)80038-5","article-title":"Prevalence and risk factors of bacteriuria in cirrhotic patients: a prospective case-control multicenter study in 244 patients","volume":"31","author":"Cadranel","year":"1999","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2019.10.003_bib0460","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/MD.0b013e318210504c","article-title":"Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores","volume":"90","author":"Viasus","year":"2011","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.clinre.2019.10.003_bib0465","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.cgh.2010.06.024","article-title":"Cirrhotic patients are at risk for health care-associated bacterial infections","volume":"8","author":"Merli","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2019.10.003_bib0470","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1086\/317494","article-title":"Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis","volume":"31","author":"Thulstrup","year":"2000","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"5","key":"10.1016\/j.clinre.2019.10.003_bib0475","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s15010-015-0794-6","article-title":"Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease","volume":"43","author":"Brandolini","year":"2015","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.clinre.2019.10.003_bib0480","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1665-2681(19)31581-9","article-title":"Prevalence and risk factors for bacterial skin infection and mortality in cirrhosis","volume":"10","author":"Mohan","year":"2011","journal-title":"Ann Hepatol"},{"issue":"3","key":"10.1016\/j.clinre.2019.10.003_bib0485","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MCG.0b013e31802dbde8","article-title":"Risk factors for the outcome of cirrhotic patients with soft tissue infections","volume":"42","author":"Liu","year":"2008","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinre.2019.10.003_bib0490","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/gutjnl-2015-310275","article-title":"Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort)","volume":"66","author":"Nahon","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2019.10.003_bib0495","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/ajg.2017.19","article-title":"Bacterial infections change natural history of cirrhosis irrespective of liver disease severity","volume":"112","author":"Dionigi","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2019.10.003_bib0500","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/liv.13195","article-title":"The impact of multidrug resistant agents in patients with cirrhosis. A multicenter prospective study","volume":"37","author":"Salerno","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2019.10.003_bib0505","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3346\/jkms.2015.30.5.598","article-title":"Clinical characteristics and prognostic impact of bacterial infections in hospitalized patients with alcoholic liver disease","volume":"30","author":"Park","year":"2015","journal-title":"J Korean Med Sci"},{"issue":"4","key":"10.1016\/j.clinre.2019.10.003_bib0510","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jceh.2017.05.003","article-title":"An insight into antibiotic resistance to bacterial infection in chronic liver disease","volume":"7","author":"Jain","year":"2017","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.clinre.2019.10.003_bib0515","first-page":"1","article-title":"Multidrug-resistant bacterial infections in cirrhotic patients: an epidemiological study","volume":"5","author":"Zhao","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2019.10.003_bib0520","article-title":"Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe","author":"Fernandez","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2019.10.003_bib0525","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0168-8278(05)80280-6","article-title":"A prospective study of bacterial infections in patients with cirrhosis","volume":"18","author":"Caly","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2019.10.003_bib0530","first-page":"788","article-title":"Bacterial infections in hepatic cirrhotic","volume":"122","author":"Toledo","year":"1994","journal-title":"Rev Med Chile"},{"key":"10.1016\/j.clinre.2019.10.003_bib0535","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clinre.2019.10.003_bib0540","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0168-8278(17)30532-9","article-title":"Resistant bacterial infections in cirrhosis: a French observational prospective multicentre nationwide study (RESIST study)","volume":"66","author":"Pauwels","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2019.10.003_bib0545","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.28332","article-title":"An empirical broad spectrum antibiotic therapy in health-care\u2013associated infections improves survival in patients with cirrhosis: a randomized trial","volume":"63","author":"Merli","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2019.10.003_bib0550","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/hep.27941","article-title":"The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial","volume":"63","author":"Piano","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clinre.2019.10.003_bib0555","doi-asserted-by":"crossref","first-page":"e1001974","DOI":"10.1371\/journal.pmed.1001974","article-title":"Antibiotic resistance in India: drivers and opportunities for Action","volume":"13","author":"Laxminarayan","year":"2016","journal-title":"Plos Med"},{"issue":"7","key":"10.1016\/j.clinre.2019.10.003_bib0560","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1097\/CCM.0000000000000321","article-title":"Improved prognosis of septic shock in patients with cirrhosis: a multicenter study","volume":"42","author":"Galbois","year":"2014","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.clinre.2019.10.003_bib0565","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jhep.2015.05.032","article-title":"Fungal infections in patients with cirrhosis","volume":"63","author":"Alexopoulou","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2019.10.003_bib0570","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/MEG.0000000000000927","article-title":"Spontaneous fungal peritonitis: a rare but severe complication of liver cirrhosis","volume":"29","author":"Gravito-Soares","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2019.10.003_bib0575","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10096-013-1953-2","article-title":"Spontaneous fungal peritonitis: a severe complication in patients with advanced liver cirrhosis","volume":"33","author":"Hwang","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.clinre.2019.10.003_bib0580","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.jhep.2016.01.039","article-title":"Prognosis of cirrhotic patients with fungiascites and spontaneous fungal peritonitis (SFP)","volume":"64","author":"Bucsics","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2019.10.003_bib0585","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4254\/wjh.v10.i2.254","article-title":"Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review","volume":"10","author":"Shizuma","year":"2018","journal-title":"World J Hepatol"},{"key":"10.1016\/j.clinre.2019.10.003_bib0590","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11046-014-9825-6","article-title":"Fungal \u201ccolonisation\u201d is associated with increased mortality in medical intensive care unit patients with liver cirrhosis","volume":"179","author":"Lahmer","year":"2015","journal-title":"Mycopathologia"},{"key":"10.1016\/j.clinre.2019.10.003_bib0595","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11046-014-9740-x","article-title":"Invasive mycosis in medical intensive care unit patients with severe alcoholic hepatitis","volume":"177","author":"Lahmer","year":"2014","journal-title":"Mycopathologia"},{"key":"10.1016\/j.clinre.2019.10.003_bib0600","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00134-017-4717-0","article-title":"Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study","volume":"43","author":"Bassetti","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clinre.2019.10.003_bib0605","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/hep.25931","article-title":"Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis","volume":"56","author":"Arabi","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2019.10.003_bib0610","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/jac\/dkt403","article-title":"Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime","volume":"69","author":"Grohs","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinre.2019.10.003_bib0615","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/jac\/dkh282","article-title":"Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae","volume":"54","author":"Muller","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinre.2019.10.003_bib0620","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bpg.2006.07.004","article-title":"Prevention and treatment of infections in patients with cirrhosis","volume":"21","author":"Ghassemi","year":"2007","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.clinre.2019.10.003_bib0625","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2019.10.003_bib0630","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/S0168-8278(07)61818-2","article-title":"Intravenous albumin is not necessary in cirrhotic patients with spontaneous bacterial peritonitis and low-risk mortality","volume":"76","author":"Casas","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2019.10.003_bib0635","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.20829","article-title":"A randomized unblinded pilot study comparing albumin vs. hydroxyethyl starch in spontaneous bacterial peritonitis","volume":"42","author":"Fernandez","year":"2005","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clinre.2019.10.003_bib0640","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jhep.2012.06.013","article-title":"Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study","volume":"57","author":"Guevara","year":"2012","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.clinre.2019.10.003_bib0645","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jhep.2014.11.017","article-title":"Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial","volume":"62","author":"Th\u00e9venot","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2019.10.003_bib0650","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/1471-2334-14-287","article-title":"Evolving epidemiology and antimicrobial resistance in spontaneous bacterial peritonitis: a two-year observational study","volume":"14","author":"Piroth","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.clinre.2019.10.003_bib0655","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/apt.14361","article-title":"Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis","volume":"46","author":"Goel","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2019.10.003_bib0660","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinre.2019.10.003_bib0665","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/cid\/cis305","article-title":"Septic shock attributed to Candida infection: importance of empiric therapy and source control","volume":"54","author":"Kollef","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"Suppl 7","key":"10.1016\/j.clinre.2019.10.003_bib0670","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenicadult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.clinre.2019.10.003_bib0675","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinre.2019.10.003_bib0680","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/0091270007303764","article-title":"Single- and multiple-dose administration of caspofungin in patients with hepatic insufficiency: implications for safety and dosing recommendations","volume":"47","author":"Mistry","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinre.2019.10.003_bib0685","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2147\/IDR.S165676","article-title":"Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation","volume":"11","author":"Yeoh","year":"2018","journal-title":"Infect Drug Resist"},{"issue":"5","key":"10.1016\/j.clinre.2019.10.003_bib0690","doi-asserted-by":"crossref","first-page":"e027683","DOI":"10.1136\/bmjopen-2018-027683","article-title":"Analysis of the challange in implemnting guidelines to prevent the pread of multidrug-resistant gram negatives in Europe","volume":"9","author":"Tacconelli","year":"2019","journal-title":"BMJ open"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740119302244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740119302244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T17:30:04Z","timestamp":1741282204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740119302244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2210740119302244"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2019.10.003","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2019.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}